Home » Healthcare » Pharmaceuticals » Heart Failure Drugs Market

Heart Failure Drugs Market: Growth, Future Prospects & Competitive Analysis, 2018-2026

Price: $4999

Published: | Report ID: 6245 | Report Format : PDF

Market Insights

Heart failure occurs when the heart cannot pump blood at a rate sufficient to fulfill the needs of the metabolizing tissues. The heart’s pumping motion is primarily responsible for promptly delivering oxygen and nutrient-rich blood to all body cells. The human body can perform its normal functions when all the cells in the body get proper nourishment. However, the weaker heart can’t give enough blood to the cells in heart failure.

Heart failure affects almost 64.3 million individuals across the globe. The prevalence of recognized heart failure is between 1% and 2% of the overall adult population in affluent countries. Heart failure is considered a critical medical condition that generally doesn’t have a complete cure. However, when heart failure is treated with drugs and healthy lifestyle adjustments, many people with the illness can live a joyful life.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Report on the Key Takeaways

Recommended Medications for Heart Failure

Healthcare experts usually recommend a combination of medications for patients to ensure the proper treatment of heart failure. One or more medications can be prescribed based on the patient’s symptoms.

Beta-blockers:

These medications lower blood pressure and lower heart rate. It is pretty compelling and also allows you to live a healthy life by mainly reducing the symptoms and signs of heart failure and boosting overall heart function.

Positive inotropes:

People in the hospital with certain types of severe heart failure may get these drugs by IV. Positive inotropes can aid in the efficient pumping of blood and the maintenance of blood pressure.

Diuretics:

Diuretics, often known as “water tablets,” cause you to urinate more regularly and prevent fluid from building up in your body. Diuretics, such as furosemide, help reduce the fluid level in the lungs, making it easier for a human to breathe comfortably.

Vericiguat:

These newly developed medications are proving effective for treating heart failure. An oral soluble stimulator called guanylate cyclase is such a medicine, and it’s taken by mouth once a day. According to research, people with high-risk heart failure who took vericiguat had fewer heart failure hospital stays.

Recent Developments Related to Heart Failure

  • According to a new study, an Apple Watch app could help diagnose left ventricular malfunction. A left-ventricular dysfunction is a type of disorder that occurs when the heart fails to pump blood effectively. The app performed comparably to a typical 12-lead EKG in the trial. According to experts, this could allow individuals to detect and monitor heart failure without contacting their doctor.
  • As per the latest Phase 3 clinical trial findings, sacubitril-valsartan, a combination oral treatment, can effectively reduce pulmonary blood pressure. This licensed treatment can be helpful for people with pulmonary hypertension (PH) associated with heart failure.
  • The findings of the EMPRISE real-world study, which studied Jardiance’s first five years of use in the United States, add to previous findings from the landmark EMPA-REG OUTCOME® trial. In adults with type 2 diabetes and established cardiovascular disease, Jardiance reduced hospitalization for heart failure by 35% when compared to a placebo.

Major Players Working on Heart Failure

AstraZeneca, Heartseed Inc., Abbott Laboratories, Bristol-Myers Squibb, Cardiora, Sardocor Corp., Bayer HealthCare, and Palatin Technologies are among the leading companies working on developing practical solutions for heart failure.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The Most Important Reasons to Buy This Report

  • The pipeline insights feature heart failure medications with comprehensive coverage of the latest developments concerning strategic collaborations, advanced technology, and licensing.
  • Detailed coverage of recent clinical studies, R&D activities, new drug approvals, investments, and other product-related developments
  • Insights on companies working closely to develop newer solutions to overcome the limitations of existing medications

Frequently Asked Question

What is the size of Heart Failure Drugs Market?

The market for Heart Failure Drugs Market is expected to reach USD$ XX Mn in 2026.

What is the Heart Failure Drugs Market CAGR?

The Heart Failure Drugs Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Heart Failure Drugs Market?

The report is forecasted from 2018 -2026.

What is the base year considered for Heart Failure Drugs Market?

The base year of this report is 2017.

Who are the major players in this market?

AstraZeneca, Heartseed Inc., Abbott Laboratories, Bristol-Myers Squibb, Cardiora, Sardocor Corp., Bayer HealthCare. are some of the major players in the global market.

Molecular Transport Medium Market

Published:
Report ID: 35092

Angiotensin Converting Enzyme (ACE) Inhibitors Market

Published:
Report ID: 12832

Stroke Management Market

Published:
Report ID: 34872

Pulmonary Embolism Market

Published:
Report ID: 34866

Oral Macromolecular Formulation Market

Published:
Report ID: 34861

Metastatic Melanoma Cancer Diagnostics Market

Published:
Report ID: 34855

Cytomegalovirus (CMV) Infection Treatment Market

Published:
Report ID: 4417

Immune Checkpoint Inhibitors Market

Published:
Report ID: 34697

Intraosseous Devices Market

Published:
Report ID: 7197

Dermatophytic Onychomycosis Therapeutics Market

Published:
Report ID: 34653

Africa Pharmaceutical Market

Published:
Report ID: 34584

Allergic Rhinitis Treatment Market

Published:
Report ID: 34575

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN